↓ Skip to main content

Biomarkers for Alzheimer’s Disease Drug Development

Overview of attention for book
Cover of 'Biomarkers for Alzheimer’s Disease Drug Development'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Epidemiology of Dementia: The Burden on Society, the Challenges for Research
  3. Altmetric Badge
    Chapter 2 Population-Based Approaches to Alzheimer’s Disease Prevention
  4. Altmetric Badge
    Chapter 3 Systems Biology Methods for Alzheimer’s Disease Research Toward Molecular Signatures, Subtypes, and Stages and Precision Medicine: Application in Cohort Studies and Trials
  5. Altmetric Badge
    Chapter 4 CSF Lipidomics Analysis: High-Resolution Mass Spectrometry Analytical Platform
  6. Altmetric Badge
    Chapter 5 CSF N-Glycomics Using MALDI MS Techniques in Alzheimer’s Disease
  7. Altmetric Badge
    Chapter 6 MicroRNA Profiling of Alzheimer’s Disease Cerebrospinal Fluid
  8. Altmetric Badge
    Chapter 7 Validation of a Chemiluminescence Immunoassay for Measuring Amyloid-β in Human Blood Plasma
  9. Altmetric Badge
    Chapter 8 Mass Spectrometry-Based Metabolomic Multiplatform for Alzheimer’s Disease Research
  10. Altmetric Badge
    Chapter 9 Blood-Based Biomarker Screening with Agnostic Biological Definitions for an Accurate Diagnosis Within the Dimensional Spectrum of Neurodegenerative Diseases
  11. Altmetric Badge
    Chapter 10 Functional Magnetic Resonance Imaging in Alzheimer’ Disease Drug Development
  12. Altmetric Badge
    Chapter 11 Neuroimaging Methods for MRI Analysis in CSF Biomarkers Studies
  13. Altmetric Badge
    Chapter 12 Hybrid PET-MRI in Alzheimer’s Disease Research
  14. Altmetric Badge
    Chapter 13 Amyloid PET Imaging: Standardization and Integration with Other Alzheimer’s Disease Biomarkers
  15. Altmetric Badge
    Chapter 14 The Use of 18F-FDG PET in the Diagnostic Workup of Alzheimer’s Dementia
  16. Altmetric Badge
    Chapter 15 Quantification of Tau Load in Alzheimer’s Disease Clinical Trials Using Positron Emission Tomography
  17. Altmetric Badge
    Chapter 16 Imaging Neuroinflammation: Quantification of Astrocytosis in a Multitracer PET Approach
  18. Altmetric Badge
    Chapter 17 Unbiased Lipidomics and Metabolomics of Human Brain Samples
  19. Altmetric Badge
    Chapter 18 Neuropathological Assessment as an Endpoint in Clinical Trial Design
  20. Altmetric Badge
    Chapter 19 Analysis of Micro-RNA Expression by qPCR on a Microfluidics Platform for Alzheimer’s Disease Biomarker Discovery
  21. Altmetric Badge
    Chapter 20 Telomere Length Shortening in Alzheimer’s Disease: Procedures for a Causal Investigation Using Single Nucleotide Polymorphisms in a Mendelian Randomization Study
  22. Altmetric Badge
    Chapter 21 Quantifying miRNA Deregulation in Alzheimer’s Disease
  23. Altmetric Badge
    Chapter 22 Imaging of Microglial Activation in Alzheimer’s Disease by [11C]PBR28 PET
  24. Altmetric Badge
    Chapter 23 In Vivo Two-Photon Calcium Imaging of Hippocampal Neurons in Alzheimer Mouse Models
  25. Altmetric Badge
    Chapter 24 Cognitive Assessment in Alzheimer’s Disease Clinical Trials
  26. Altmetric Badge
    Chapter 25 Data Mining and Machine Learning Methods for Dementia Research
Attention for Chapter 5: CSF N-Glycomics Using MALDI MS Techniques in Alzheimer’s Disease
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
18 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
CSF N-Glycomics Using MALDI MS Techniques in Alzheimer’s Disease
Chapter number 5
Book title
Biomarkers for Alzheimer’s Disease Drug Development
Published in
Methods in molecular biology, January 2018
DOI 10.1007/978-1-4939-7704-8_5
Pubmed ID
Book ISBNs
978-1-4939-7703-1, 978-1-4939-7704-8
Authors

Angelo Palmigiano, Angela Messina, Rosaria Ornella Bua, Rita Barone, Luisa Sturiale, Mario Zappia, Domenico Garozzo, Palmigiano, Angelo, Messina, Angela, Bua, Rosaria Ornella, Barone, Rita, Sturiale, Luisa, Zappia, Mario, Garozzo, Domenico

Abstract

In this chapter, we present the methodology currently applied in our laboratory for the structural elucidation of the cerebrospinal fluid (CSF) N-glycome. N-glycans are released from denatured carboxymethylated glycoproteins by digestion with peptide-N-glycosidase F (PNGase F) and purified using both C18 Sep-Pak® and porous graphitized carbon (PGC) HyperSep™ Hypercarb™ solid-phase extraction (SPE) cartridges. The glycan pool is subsequently permethylated to increase mass spectrometry sensitivity. Molecular assignments are performed through matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI TOF MS) analysis considering either the protein N-linked glycosylation pathway or MALDI TOF MS/MS data. Each stage has been optimized to obtain high-quality mass spectra in reflector mode with an optimal signal-to-noise ratio up to m/z 4800. This method has been successfully adopted to associate specific N-glycome profiles to the early and the advanced phases of Alzheimer's disease.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 22%
Student > Master 3 17%
Professor 2 11%
Lecturer > Senior Lecturer 1 6%
Other 1 6%
Other 2 11%
Unknown 5 28%
Readers by discipline Count As %
Medicine and Dentistry 4 22%
Biochemistry, Genetics and Molecular Biology 2 11%
Veterinary Science and Veterinary Medicine 1 6%
Immunology and Microbiology 1 6%
Agricultural and Biological Sciences 1 6%
Other 2 11%
Unknown 7 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 March 2018.
All research outputs
#20,468,008
of 23,026,672 outputs
Outputs from Methods in molecular biology
#9,951
of 13,170 outputs
Outputs of similar age
#378,209
of 442,370 outputs
Outputs of similar age from Methods in molecular biology
#1,194
of 1,499 outputs
Altmetric has tracked 23,026,672 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 13,170 research outputs from this source. They receive a mean Attention Score of 3.4. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 442,370 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,499 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.